1[1]Yoo CH, Noh SH, Shin DW, et al. Recurrence following curative resection for gastric carcinoma[J]. Br J Surg, 2000, 87(2): 236-242.
2[2]Sugarbaker PH, Graves T, DeBruijn EA, et al. Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies[J]. Cancer Res, 1990, 50(18): 5790-5794.
3[3]Sugarbaker PH. Peritoneal carcinomatosis: natural history and rational therapeutic interventions using intraperitoneal chemotherapy[J]. Cancer Treat Res, 1996, 81149-81168.
4[4]Noh SH, Yoo CH, Chung HC, et al. Early postoperative intraperitoneal chemotherapy with mitomycin C, 5-fluorouracil and cisplatin for advanced gastric cancer[J]. Oncology, 2001, 60(1): 24-30.
5[5]Makhija S, Sabbatini P, Aghajanian C, et al. Intraperito-neal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian cancer patients with a positive second look[J]. Gynecol Oncol, 2000, 79(1): 28-32.
6[6]Favoulet P, Magnin G, Guilland JC, et al. Pre-clinical study of the epinephrine-cisplatin association for the treatment of intraperitoneal carcinomatosis[J]. Eur J Surg Oncol, 2001, 27(1): 59-64.
7[7]Flessner MF, Lofthouse J, Zakaria ER. Improving contact area between the peritoneum and intraperitoneal therapeutic solutions[J]. J Am Soc Nephrol, 2001, 12(4): 807-813.
8[8]Pestieau SR, Schnake KJ, Stuart OA, et al. Impact of carrier solutions on pharmacokinetics of intraperitoneal chemotherapy[J]. Cancer Chemother Pharmacol, 2001, 47(3): 269-276.
9[9]Hosie K,Gilbert JA, Kerr D,et al. Fluid dynamics in man of an intraperitoneal drug delivery solution: 4% icodextrin[J]. Drug Deliv, 2001, 8(1): 9-12.
10[10]Tsujitani S, Oka A, Kondo A, et al. Administration in a hypotonic solution is preferable to dose escalation in intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in rats[J]. Oncology , 1999, 57(1): 77-82.
4Sugarbaker P H, Graves T, Debruijn E A, et al. Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies [ J ]. Cancer Res, 1990, 50 ( 18 ):5790-5794.
5夏穗生主编.现代腹部外科[M].武汉:湖北科学技术出版社,1996:207.
6Sugarbaker PH. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrontestineal cancer [ J ]. Seminar Oncol, 1989,16(4) :83
7Brenner DE. Intraperitoneal chemotherapy: a review [ J ] . J clin Oncol,1986,4(7) : 1 135
8Pestieau SR, Schnake KJ, Stuart OA, et al. Impact of carrier solutions on pharmacokinetics of intraperitoneal chemotherapy [ J ]. Cancer Chemother Pharmacol,2001,47(3) :269
9Adam YG, Efron G.Trends and controversies in the management of carcinoma of the stomach[J] ,Surg Gynecol Obstet, 1989,169(4) :371
10Nomura E, Niki M, Fujii K, et al. Efficacy of intraperitoneal and intravenous chemotherapy and left upper abdominal evisceration for advanced gastric cancer[J]. Gastric Cancer, 2001,4(2) :75
